Normalizing PL activity chemogenetically decreased the number of GAD1+/ VGLUT1+ neurons in the PL of PCP and METH-treated mice to the level of controls (588 ± 27 and 575 ± 9 vs 1225 ± 38 and 1071 ± 42) (Fig. 7a–c). The gene discussed is SLC17A7; the disease is pneumocystosis.